ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,000 | -30.3% | 250 | -55.2% | 0.02% | -37.5% |
| Q3 2021 | $33,000 | -5.7% | 558 | +8.1% | 0.02% | -7.7% |
| Q2 2021 | $35,000 | +150.0% | 516 | +155.4% | 0.03% | +136.4% |
| Q1 2021 | $14,000 | -30.0% | 202 | -22.3% | 0.01% | -35.3% |
| Q4 2020 | $20,000 | -72.2% | 260 | -73.1% | 0.02% | -73.8% |
| Q3 2020 | $72,000 | +1100.0% | 968 | +858.4% | 0.06% | +828.6% |
| Q2 2020 | $6,000 | – | 101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |